Borrelli et al. (2013) [50] demonstrated that CBG attenuates murine colitis by reducing nitric oxide production and inducible nitric oxide synthase (iNOS) protein expression in macrophages, an effect modulated by CB2R, along with antioxidant and anti-inflammatory actions. The gene discussed is NOS2; the disease is colitis.